Maxlinear, Inc (MXL) — SEC Filings
Maxlinear, Inc (MXL) — 28 SEC filings. Latest: 10-Q (Apr 23, 2026). Includes 9 8-K, 7 SC 13G/A, 6 10-Q.
View Maxlinear, Inc on SEC EDGAR
Overview
Maxlinear, Inc (MXL) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Nov 24, 2025: MaxLinear, Inc. filed an 8-K on November 24, 2025, reporting events on November 20, 2025. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." Specific details regarding the nature of these events or financial statements are not provided in the excerpt.
Sentiment Summary
Across 28 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 24 neutral, 2 mixed. The dominant filing sentiment for Maxlinear, Inc is neutral.
Filing Type Overview
Maxlinear, Inc (MXL) has filed 6 10-Q, 9 8-K, 1 DEFA14A, 2 DEF 14A, 1 10-K, 7 SC 13G/A, 2 SC 13G with the SEC between Jan 2024 to Apr 2026.
Filings by Year
Recent SEC Filings (28)
Risk Profile
Risk Assessment: Of MXL's 16 recent filings, 1 were flagged as high-risk, 8 as medium-risk, and 7 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $126.459M |
| Net Income | $(45.485M) |
| EPS | N/A |
| Debt-to-Equity | 0.29 |
| Cash Position | $111.859M |
| Operating Margin | -32.6% |
| Total Assets | $808.133M |
| Total Debt | $123.461M |
Key Executives
- Dr. Theodore Tewksbury
- Kishore Seendripu
- Steven D. Lyle
- Steven G. Litchfield
- Dr. H.K. Lee
- Mr. David W. Schramm
- Steven J. Lyle
- Adam A. Smith
- December 29, 2023
Industry Context
MaxLinear operates within the highly competitive semiconductor industry, specifically focusing on System-on-Chips (SoCs) for communication infrastructure. Key markets include broadband, data center, and industrial applications. The industry is characterized by rapid technological advancements, cyclical demand, and significant R&D investment requirements. Companies like MaxLinear must continuously innovate to maintain market share and meet the evolving needs of customers in areas like high-speed data transmission and connectivity.
Top Tags
semiconductors (4) · 10-Q (3) · financials (3) · institutional-ownership (3) · Semiconductors (2) · Net Loss (2) · corporate-governance (2) · filing (2) · shareholder-meeting (2) · executive-compensation (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Revenue (Q3 2025) | $126.459M | Increased 55.9% from $81.102M in Q3 2024 |
| Net Loss (Q3 2025) | $(45.485M) | Improved from $(75.785M) in Q3 2024 |
| Net Revenue (YTD 2025) | $331.205M | Increased 23.4% from $268.361M in YTD 2024 |
| Net Loss (YTD 2025) | $(121.784M) | Improved from $(187.360M) in YTD 2024 |
| Cash and Cash Equivalents | $111.859M | Decreased from $118.575M at Dec 31, 2024 |
| Accumulated Deficit | $(485.509M) | Expanded from $(363.725M) at Dec 31, 2024 |
| Restructuring Charges (Q3 2025) | $11.264M | Lower than $26.828M in Q3 2024 |
| Net Cash from Operating Activities (YTD 2025) | $9.213M | Positive, compared to $(17.457M) used in YTD 2024 |
| Common Shares Outstanding | 87,372,834 | As of October 15, 2025 |
| Q2 2025 Revenue | $120.0M | Down 15% from Q2 2024, indicating significant sales decline. |
| Q2 2025 Net Income | -$10.0M | Swing from $5.0M net income in Q2 2024 to a net loss, highlighting profitability issues. |
| Revenue Decrease | 15% | Percentage drop in revenue year-over-year for Q2, signaling market challenges. |
| Q2 2025 R&D Expenses | $45.0M | Increased by 5% from Q2 2024, showing continued investment despite revenue decline. |
| Q2 2025 SG&A Expenses | $25.0M | Reduced by 10% from Q2 2024, indicating cost-cutting efforts. |
| Contract Termination Charge | $2.0M | Incurred during the first six months of 2025, impacting profitability. |
Forward-Looking Statements
- {"claim":"MaxLinear Inc. stock may experience increased stability due to institutional backing.","entity":"MaxLinear Inc.","targetDate":"next 6-12 months","confidence":"medium"}
- {"claim":"Other institutional investors might increase their positions in MaxLinear Inc. following Invesco's disclosure.","entity":"MaxLinear Inc.","targetDate":"next 3-6 months","confidence":"low"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Maxlinear, Inc (MXL)?
Maxlinear, Inc has 28 recent SEC filings from Jan 2024 to Apr 2026, including 9 8-K, 7 SC 13G/A, 6 10-Q. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of MXL filings?
Across 28 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 24 neutral, 2 mixed. The dominant sentiment is neutral.
Where can I find Maxlinear, Inc SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Maxlinear, Inc (MXL) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Maxlinear, Inc?
Key financial highlights from Maxlinear, Inc's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for MXL?
The investment thesis for MXL includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Maxlinear, Inc?
Key executives identified across Maxlinear, Inc's filings include Dr. Theodore Tewksbury, Kishore Seendripu, Steven D. Lyle, Steven G. Litchfield, Dr. H.K. Lee and 4 others.
What are the main risk factors for Maxlinear, Inc stock?
Of MXL's 16 assessed filings, 1 were flagged high-risk, 8 medium-risk, and 7 low-risk.
What are recent predictions and forward guidance from Maxlinear, Inc?
Recent forward-looking statements from Maxlinear, Inc include guidance on {"claim":"MaxLinear Inc. stock may experience increased stability due to institutional backing.","entity":"MaxLinear Inc and 1 other predictions.